Evidence map›Paper›PMID 40127668›Full record

ArticleThe Lancet. Oncology2025

Carcinogenicity of automotive gasoline and some oxygenated gasoline additives.

Michelle C Turner, Lode Godderis, Pascal Guénel, Nancy Hopf, Betzabet Quintanilla-Vega, Sheila C Soares-Lima, Sunisa Chaiklieng, Juliana Da Silva, Silvia Fustinoni, Min Gi and 27 more

Erratum issuedAbstract read
In one paragraph

Article in The Lancet. Oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Systematic evaluation of the evidence base on ethylCurrent research in toxicology · 2026
    Review
  10. Article
  11. Article
  12. Occupational Exposure to Engine Exhausts and Prostate Cancer Risk.Environmental health : a global access science source · 2025
    Article
  13. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

37 authors.

Michelle C TurnerInternational Agency for Research on Cancer, Lyon, France.
Lode GodderisInternational Agency for Research on Cancer, Lyon, France.
Pascal GuénelInternational Agency for Research on Cancer, Lyon, France.
Nancy HopfInternational Agency for Research on Cancer, Lyon, France.
Betzabet Quintanilla-VegaInternational Agency for Research on Cancer, Lyon, France.
Sheila C Soares-LimaInternational Agency for Research on Cancer, Lyon, France.
Sunisa ChaikliengInternational Agency for Research on Cancer, Lyon, France.
Juliana Da SilvaInternational Agency for Research on Cancer, Lyon, France.
Silvia FustinoniInternational Agency for Research on Cancer, Lyon, France.
Min GiInternational Agency for Research on Cancer, Lyon, France.
Julia E HeckInternational Agency for Research on Cancer, Lyon, France.
François HuauxInternational Agency for Research on Cancer, Lyon, France.
Gunnar JohansonInternational Agency for Research on Cancer, Lyon, France.
Jorunn KirkeleitInternational Agency for Research on Cancer, Lyon, France.
Kirill KirsanovInternational Agency for Research on Cancer, Lyon, France.
Lorenzo RichiardiInternational Agency for Research on Cancer, Lyon, France.
João Paulo TeixeiraInternational Agency for Research on Cancer, Lyon, France.
Andrea TerronInternational Agency for Research on Cancer, Lyon, France.
Jan TopinkaInternational Agency for Research on Cancer, Lyon, France.
Mary C WhiteInternational Agency for Research on Cancer, Lyon, France.
Lamia Benbrahim-TallaaInternational Agency for Research on Cancer, Lyon, France.
Caterina FacchinInternational Agency for Research on Cancer, Lyon, France.
Andrew KunzmannInternational Agency for Research on Cancer, Lyon, France.
Federica MadiaInternational Agency for Research on Cancer, Lyon, France.
Elisa PasqualInternational Agency for Research on Cancer, Lyon, France.
Roland WedekindInternational Agency for Research on Cancer, Lyon, France.
Xiaobei DengInternational Agency for Research on Cancer, Lyon, France.
Eero SuonioInternational Agency for Research on Cancer, Lyon, France.
Susana ViegasInternational Agency for Research on Cancer, Lyon, France.
Abdoulaye BarryInternational Agency for Research on Cancer, Lyon, France.
Roya DolatkhahInternational Agency for Research on Cancer, Lyon, France.
Rachmad A DongoranInternational Agency for Research on Cancer, Lyon, France.
Esther M Gonzalez-GilInternational Agency for Research on Cancer, Lyon, France.
Felix M OnyijeInternational Agency for Research on Cancer, Lyon, France.
Heidi MattockInternational Agency for Research on Cancer, Lyon, France.
Aline de ContiInternational Agency for Research on Cancer, Lyon, France.
Mary K Schubauer-BeriganInternational Agency for Research on Cancer, Lyon, France.

Funding

EVALUATION OF CARCINOGENIC RISKS TO HUMANSU01CA033193 · NCI · INTERNATIONAL AGENCY FOR RES ON CANCER · PI SCHUBAUER-BERIGAN, MARY K. · 1985 to 2020
$16.5M
IARC Monographs on the Identification of Carcinogenic Hazards to HumansR01CA033193 · NCI · INTERNATIONAL AGENCY FOR RES ON CANCER · PI SCHUBAUER-BERIGAN, MARY K. · 2021 to 2025
$4.9M
NCI NIH HHS R01 CA033193NCI NIH HHS U01 CA033193World Health Organization 001
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID40127668
PMCPMC12303572

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.